Original Research

DOI: 10.4244/EIJ-D-23-00469

Contemporary guideline-directed management of patients with severe aortic valve stenosis

Xi Wang1,2, MD, PhD; Ketina Arslani1, MD; Philippe Nuyens1, MD; Nicholas J. Montarello1, MD; Maarten Vanhaverbeke1, MD, PhD; Gintautas Bieliauskas1, MD; Lars Sondergaard3, MD, DMSc; Ole De Backer1, MD, PhD


BACKGROUND: Both surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are Class Ia recommended therapies for specific subgroups of severe aortic stenosis (AS) patients in the latest 2021 European guidelines.

AIMS: We aimed to report on the multidisciplinary Heart Team evaluation process and real-world practice of treating severe symptomatic AS in East Denmark in the context of the latest European guideline recommendations.

METHODS: All consecutive patients with severe AS referred for intervention in 2021 (N=672) were discussed in a multidisciplinary Heart Team meeting. All patients (100%) had a cardiac computed tomography (CT) analysis prior to the meeting. Baseline characteristics, Heart Team decision-making, final treatment and 30-day clinical outcomes were prospectively recorded.

RESULTS: The majority of severe AS patients (N=456, 68%) were referred for TAVI following discussion in the Heart Team. Ultimately, 94% of patients (N=632) received the Heart Team-recommended treatment. Patients undergoing TAVI (N=439) were significantly older (78.4±6.7 vs 67.2±8.3 years; p<0.001) and more comorbid than patients undergoing SAVR (N=189). The overall 30-day clinical outcomes were satisfactory for both treatment groups (overall 30-day mortality: 1.1%)....

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 2
Jan 15, 2024
Volume 20 Number 2
View full issue

Key metrics

On the same subject


10.4244/EIJY16M06_01 Sep 18, 2016
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey
Petronio AS et al


10.4244/EIJ-E-23-00065 Jan 15, 2024
Aortic stenosis management: current evolution and future challenges
Scotti A and Latib A

Research correspondence

10.4244/EIJ-D-22-00493 Jan 23, 2023
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection
Vanhaverbeke M et al

10.4244/EIJV11I4A76 Aug 20, 2015
CAD in TAVI patients: relevance of disease complexity
Stefanini G and Panico C

10.4244/EIJV15I12A191 Dec 20, 2019
The role of the Heart Team in the planning of aortic valve replacement
Costa G et al

10.4244/EIJV15I11A179 Dec 6, 2019
Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?
Galper B et al
Trending articles

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al


10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al


10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved